Susquehanna International Group’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $588K | Sell |
210,745
-19,032
| -8% | -$64.7K | ﹤0.01% | 9242 |
|
|
2025
Q4 | $841K | Sell |
229,777
-126,401
| -35% | -$360K | ﹤0.01% | 7568 |
|
|
2025
Q3 | $1.32M | Buy |
356,178
+310,543
| +680% | +$785K | ﹤0.01% | 6677 |
|
|
2025
Q2 | $84.9K | Buy |
+45,635
| New | +$79K | ﹤0.01% | 11877 |
|
|
2025
Q1 | – | Sell |
-59,213
| Closed | -$104K | – | 12746 |
|
|
2024
Q4 | $120K | Buy |
59,213
+39,351
| +198% | +$71.3K | ﹤0.01% | 11191 |
|
|
2024
Q3 | $28.7K | Buy |
19,862
+1,011
| +5% | +$1.93K | ﹤0.01% | 11542 |
|
|
2024
Q2 | $32.2K | Buy |
+18,851
| New | +$34.2K | ﹤0.01% | 11543 |
|
|
2023
Q3 | – | Sell |
-905
| Closed | -$6.21K | – | 12268 |
|
|
2023
Q2 | $7.47K | Buy |
+905
| New | +$8.95K | ﹤0.01% | 11796 |
|
|
2022
Q3 | – | Sell |
-6,267
| Closed | -$79K | – | 13435 |
|
|
2022
Q2 | $79K | Buy |
6,267
+2,009
| +47% | +$29.8K | ﹤0.01% | 11672 |
|
|
2022
Q1 | $87K | Sell |
4,258
-1,968
| -32% | -$53.9K | ﹤0.01% | 11997 |
|
|
2021
Q4 | $233K | Buy |
6,226
+2,528
| +68% | +$113K | ﹤0.01% | 11109 |
|
|
2021
Q3 | $179K | Buy |
3,698
+431
| +13% | +$21K | ﹤0.01% | 11614 |
|
|
2021
Q2 | $175K | Buy |
+3,267
| New | +$197K | ﹤0.01% | 11726 |
|
|
2021
Q1 | – | Sell |
-908
| Closed | -$43K | – | 12395 |
|
|
2020
Q4 | $43K | Buy |
+908
| New | +$39.3K | ﹤0.01% | 10779 |
|
|
2020
Q2 | – | Sell |
-24,117
| Closed | -$684K | – | 10320 |
|
|
2020
Q1 | $684K | Buy |
24,117
+16,880
| +233% | +$560K | ﹤0.01% | 6250 |
|
|
2019
Q4 | $279K | Buy |
+7,237
| New | +$186K | ﹤0.01% | 8163 |
|
|
2019
Q1 | – | Sell |
-1,137
| Closed | -$29.8K | – | 9113 |
|
|
2018
Q4 | $15K | Buy |
+1,137
| New | +$19K | ﹤0.01% | 8712 |
|
|
2018
Q3 | – | Sell |
-1,040
| Closed | -$47K | – | 9501 |
|
|
2018
Q2 | $47K | Buy |
+1,040
| New | +$58.6K | ﹤0.01% | 9290 |
|
|
2018
Q1 | – | Sell |
-706
| Closed | -$44.7K | – | 9525 |
|
|
2017
Q4 | $42K | Buy |
+706
| New | +$41.6K | ﹤0.01% | 8951 |
|
|
2017
Q3 | – | Sell |
-1,508
| Closed | -$102K | – | 9033 |
|
|
2017
Q2 | $107K | Buy |
1,508
+277
| +23% | +$16.4K | ﹤0.01% | 8658 |
|
|
2017
Q1 | $68K | Sell |
1,231
-1,662
| -57% | -$74.4K | ﹤0.01% | 8515 |
|
|
2016
Q4 | $117K | Buy |
+2,893
| New | +$108K | ﹤0.01% | 8998 |
|
|
2016
Q2 | – | Sell |
-2,899
| Closed | -$135K | – | 8739 |
|
|
2016
Q1 | $135K | Buy |
+2,899
| New | +$122K | ﹤0.01% | 8277 |
|
|
2015
Q3 | – | Sell |
-2,789
| Closed | -$141K | – | 9737 |
|
|
2015
Q2 | $141K | Buy |
2,789
+301
| +12% | +$15.4K | ﹤0.01% | 9518 |
|
|
2015
Q1 | $144K | Sell |
2,488
-2,213
| -47% | -$92.2K | ﹤0.01% | 8824 |
|
|
2014
Q4 | $172K | Sell |
4,701
-1,051
| -18% | -$31K | ﹤0.01% | 8927 |
|
|
2014
Q3 | $181K | Sell |
5,752
-22,993
| -80% | -$611K | ﹤0.01% | 8761 |
|
|
2014
Q2 | $741K | Buy |
28,745
+21,404
| +292% | +$564K | ﹤0.01% | 6683 |
|
|
2014
Q1 | $218K | Buy |
7,341
+6,317
| +617% | +$246K | ﹤0.01% | 8103 |
|
|
2013
Q4 | $40K | Buy |
+1,024
| New | +$39.5K | ﹤0.01% | 8832 |
|
|
2013
Q3 | – | Sell |
-2,398
| Closed | -$294K | – | 8489 |
|
|
2013
Q2 | $309K | Buy |
+2,398
| New | +$354K | ﹤0.01% | 6760 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Susquehanna International Group's FBIO Position: Q1 2026 in Review
Susquehanna International Group reduced its Fortress Biotech (FBIO) stake by 8.3% in Q1 2026, selling an estimated $64.7K and leaving 210,745 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #9242.
Susquehanna International Group first reported a position in FBIO in Q2 2013 and has held it in 31 quarters since. The position peaked at $1.32M in Q3 2025. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Susquehanna International Group held 210,745 shares of Fortress Biotech worth $588K as of Q1 2026.
- Susquehanna International Group sold 19,032 Fortress Biotech shares in Q1 2026, an estimated $64.7K.
- Fortress Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9242 holding.
- Susquehanna International Group first reported a position in Fortress Biotech in Q2 2013 and has held it in 31 quarters since.
- Susquehanna International Group's Fortress Biotech position peaked at $1.32M in Q3 2025.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.